Cargando…

Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System

INTRODUCTION: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Alva, Shridhara, Brazg, Ronald, Castorino, Kristin, Kipnes, Mark, Liljenquist, David R., Liu, Hanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064376/
https://www.ncbi.nlm.nih.gov/pubmed/36877403
http://dx.doi.org/10.1007/s13300-023-01385-6
_version_ 1785017887246778368
author Alva, Shridhara
Brazg, Ronald
Castorino, Kristin
Kipnes, Mark
Liljenquist, David R.
Liu, Hanqing
author_facet Alva, Shridhara
Brazg, Ronald
Castorino, Kristin
Kipnes, Mark
Liljenquist, David R.
Liu, Hanqing
author_sort Alva, Shridhara
collection PubMed
description INTRODUCTION: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 years. The analytical performance of the third-generation factory-calibrated FSL3 CGM system was compared to the plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer (the YSI reference) and the self-monitoring blood glucose (SMBG) reference for participants aged ≥ 6 years and participants aged 4 and 5 years, respectively. METHODS: A total of 108 participants aged ≥ 4 years with type 1 or type 2 diabetes from four sites in the USA were enrolled in the study. The data of 100 participants were ultimately evaluated. Adult participants (aged ≥ 18 years) participated in three in-clinic sessions, and pediatric participants (aged 4–17 years) participated in up to two in-clinic sessions, all stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13 or 14 of sensor wear. Performance evaluation included accuracy measures, such as proportion of CGM values that fell within ± 20% or ± 20 mg/dL (1.1 mmol/L) of the reference glucose values, and difference measures, such as the mean absolute relative difference (MARD) between the CGM and reference values. RESULTS: Data from the 100 study participants were analyzed. The overall MARD was 7.8%, and 93.4% of the CGM values were within ± 20% or ± 20 mg/dL of the YSI reference for participants aged ≥ 6 years, with 6845 CGM-YSI matched pairs. The performance was stable over the 14-day wear period. For participants aged 4–5 years, MARD was 10.0%, and 88.9% of the CGM values were within 20%/20 mg/dL compared to a SMBG reference. No serious adverse events were reported. CONCLUSIONS: The FSL3 CGM system demonstrated accurate performance across the dynamic glycemic range during the 14-day sensor wear period.
format Online
Article
Text
id pubmed-10064376
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-100643762023-04-01 Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System Alva, Shridhara Brazg, Ronald Castorino, Kristin Kipnes, Mark Liljenquist, David R. Liu, Hanqing Diabetes Ther Original Research INTRODUCTION: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 years. The analytical performance of the third-generation factory-calibrated FSL3 CGM system was compared to the plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer (the YSI reference) and the self-monitoring blood glucose (SMBG) reference for participants aged ≥ 6 years and participants aged 4 and 5 years, respectively. METHODS: A total of 108 participants aged ≥ 4 years with type 1 or type 2 diabetes from four sites in the USA were enrolled in the study. The data of 100 participants were ultimately evaluated. Adult participants (aged ≥ 18 years) participated in three in-clinic sessions, and pediatric participants (aged 4–17 years) participated in up to two in-clinic sessions, all stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13 or 14 of sensor wear. Performance evaluation included accuracy measures, such as proportion of CGM values that fell within ± 20% or ± 20 mg/dL (1.1 mmol/L) of the reference glucose values, and difference measures, such as the mean absolute relative difference (MARD) between the CGM and reference values. RESULTS: Data from the 100 study participants were analyzed. The overall MARD was 7.8%, and 93.4% of the CGM values were within ± 20% or ± 20 mg/dL of the YSI reference for participants aged ≥ 6 years, with 6845 CGM-YSI matched pairs. The performance was stable over the 14-day wear period. For participants aged 4–5 years, MARD was 10.0%, and 88.9% of the CGM values were within 20%/20 mg/dL compared to a SMBG reference. No serious adverse events were reported. CONCLUSIONS: The FSL3 CGM system demonstrated accurate performance across the dynamic glycemic range during the 14-day sensor wear period. Springer Healthcare 2023-03-06 2023-04 /pmc/articles/PMC10064376/ /pubmed/36877403 http://dx.doi.org/10.1007/s13300-023-01385-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Alva, Shridhara
Brazg, Ronald
Castorino, Kristin
Kipnes, Mark
Liljenquist, David R.
Liu, Hanqing
Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
title Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
title_full Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
title_fullStr Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
title_full_unstemmed Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
title_short Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
title_sort accuracy of the third generation of a 14-day continuous glucose monitoring system
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064376/
https://www.ncbi.nlm.nih.gov/pubmed/36877403
http://dx.doi.org/10.1007/s13300-023-01385-6
work_keys_str_mv AT alvashridhara accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem
AT brazgronald accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem
AT castorinokristin accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem
AT kipnesmark accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem
AT liljenquistdavidr accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem
AT liuhanqing accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem